Delivery Order SPE2DB20D2104-SPE2DB25FNAHV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in a 100 ml pack. The contract was competitively awarded without set-aside designation under firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,412.50 on August 29, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs, with a ceiling value of $1,682.50 and an ultimate completion date of September 8, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken,...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, valued at $1,280.92 with a firm fixed price contract type. The award was not set aside for small businesses or other designated groups and carries an ultimate completion date of September 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a $2,523.75 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Epidiolex 100 mg/ml solution in 100ml packs. This is a firm fixed-price delivery order with a completion date of September 23, 2025, and represents a non-set-aside competitive award. The contract will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Epidiolex 100 mg/ml solution in 100ml packs, with a ceiling value of $1,682.50 and a firm fixed price structure. This delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs, with a ceiling value of $3,842.76. This competitively awarded, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of September 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from...
- The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packaging, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside transaction and leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at...
- The Defense Logistics Agency awarded a $8,412.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in a 100 ml pack, with delivery to the company's corporate office location in Conshohocken, Pennsylvania. The award was made on July 23, 2025, with an ultimate completion date of August 13, 2025, and was not designated as a set-aside contract. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide Epidiolex 100 mg/ml solution in a 100 ml pack. The contract has a completion date of February 16, 2024, and a potential value of $1,626.30. Amerisourcebergen Drug Corporation is the prime contractor on this delivery order, which is part of a larger indefinite...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAHVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,523.75 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs on September 12, 2025, with an ultimate completion date of October 3, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This particular order for Epidiolex, an FDA-approved cannabidiol medication used to treat certain seizure disorders, reflects the company's role in supporting the Defense Health Agency and other military healthcare systems. The award was competitively procured, demonstrating AmerisourceBergen's capability to meet federal procurement requirements and its position as one of multiple contractors anticipated under the DLA's evolving Pharmaceutical Prime Vendor Global Program Generation V contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/12/25 |